[{"data":1,"prerenderedAt":25},["ShallowReactive",2],{"$fEpmnYvdZC_Y71x-jm5QU2Tb6GccpgqZjHup4AdUZN0A":3},{"card":4,"examId":6,"chapterTitle":22,"prev":23,"next":24},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":12,"explanation":13,"explanationDetail":14,"mistakeHint":15,"lectureRef":16,"storyRef":16,"chapterSlug":17,"sectionCode":18,"sectionTitle":19,"clusterSlug":20,"term":16,"sequenceOrder":16,"regionWeight":16,"revisionMark":16,"isActive":21},"ch1-022","touhan","ヒトを対象とした医薬品の臨床試験の国際基準はGLPと呼ばれる。",1,[10,11],"正しい","誤り","ox","ヒトを対象とした臨床試験の基準は「GCP」です。「GLP」は動物実験などの非臨床試験の基準となるため誤りです。","どちらも医薬品の安全性を確保するための重要な基準ですが、対象が「ヒト」か「動物」かで呼び方が変わります。","「非臨床試験＝GLP」「臨床試験（ヒト）＝GCP」の対象を逆にする引っかけは非常によく出題されます。注意しましょう。",null,"chapter-1","1-I-2","医薬品のリスク評価","risk-hyouka",true,"第1章 医薬品に共通する特性と基本的な知識","ch1-021","ch1-023",1784619073792]